CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011	Dec. 31, 2010
Revenues	$ 493,774	$ 435,770	$ 998,523	$ 1,119,672
Cost of Goods Sold	382,454	342,980	747,909	674,645
Gross Profit	111,320	92,790	250,614	445,027
Research and Development Expenses, net	149,044	246,093	300,234	473,587
Selling, General and Administrative Expenses	274,718	180,657	528,074	460,429
Gain on Sale of Assets	(99)	(17,938)	(2,149)	(29,991)
Total Operating Expenses	423,663	408,812	826,159	904,025
Operating Loss	(312,343)	(316,022)	(575,545)	(458,998)
Gain on Sale of Patents			2,276,286
Interest Income	176	72	533	202
Interest Expense	(12,708)	(15,000)	(27,708)	(30,000)
Net Income (Loss)	$ (324,875)	$ (330,950)	$ 1,673,566	$ (488,796)
Income (Loss) Per Share:
Basic (in Dollars per share)	$ (0.27)	$ (0.33)	$ 1.55	$ (0.48)
Diluted (in Dollars per share)	$ (0.27)	$ (0.33)	$ 1.47	$ (0.48)
Weighted Average Common Shares Outstanding:
Basic (in Shares)	1,191,138	1,017,896	1,081,075	1,018,153
Diluted (in Shares)	1,191,138	1,017,896	1,160,355	1,018,153